Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ)
CNY 2.36
(-1.26%)
CNY 2.36
(-1.26%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.58 Billion CNY | -16.67% |
| 2022 | 3.1 Billion CNY | -1.19% |
| 2021 | 3.14 Billion CNY | 2.96% |
| 2020 | 3.05 Billion CNY | -39.55% |
| 2019 | 5.05 Billion CNY | -7.8% |
| 2018 | 5.48 Billion CNY | 80.2% |
| 2017 | 3.04 Billion CNY | 1.95% |
| 2016 | 2.98 Billion CNY | 11.28% |
| 2015 | 2.68 Billion CNY | 40.69% |
| 2014 | 1.9 Billion CNY | 45.72% |
| 2013 | 1.3 Billion CNY | 83.94% |
| 2012 | 711.03 Million CNY | 30.14% |
| 2011 | 546.36 Million CNY | -5.05% |
| 2010 | 575.44 Million CNY | 33.85% |
| 2009 | 429.92 Million CNY | 55.99% |
| 2008 | 275.61 Million CNY | 67.94% |
| 2007 | 164.11 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 586.07 Million CNY | 3.52% |
| 2024 Q3 | 636.19 Million CNY | 2.92% |
| 2024 Q2 | 618.15 Million CNY | 5.47% |
| 2023 Q1 | 681.16 Million CNY | -1.69% |
| 2023 Q3 | 619.34 Million CNY | -17.58% |
| 2023 Q4 | 566.17 Million CNY | -8.59% |
| 2023 FY | 2.58 Billion CNY | -16.67% |
| 2023 Q2 | 751.49 Million CNY | 10.32% |
| 2022 Q2 | 825.35 Million CNY | 6.61% |
| 2022 Q1 | 774.21 Million CNY | -6.4% |
| 2022 Q4 | 692.88 Million CNY | -15.03% |
| 2022 Q3 | 815.48 Million CNY | -1.2% |
| 2022 FY | 3.1 Billion CNY | -1.19% |
| 2021 Q2 | 832.21 Million CNY | 18.01% |
| 2021 FY | 3.14 Billion CNY | 2.96% |
| 2021 Q3 | 780.75 Million CNY | -6.18% |
| 2021 Q1 | 705.23 Million CNY | -16.09% |
| 2021 Q4 | 827.1 Million CNY | 5.94% |
| 2020 Q1 | 581.01 Million CNY | -46.05% |
| 2020 FY | 3.05 Billion CNY | -39.55% |
| 2020 Q3 | 809.49 Million CNY | -1.76% |
| 2020 Q4 | 840.41 Million CNY | 3.82% |
| 2020 Q2 | 824.01 Million CNY | 41.82% |
| 2019 FY | 5.05 Billion CNY | -7.8% |
| 2019 Q1 | 1.25 Billion CNY | -17.13% |
| 2019 Q2 | 1.47 Billion CNY | 17.14% |
| 2019 Q3 | 1.24 Billion CNY | -15.75% |
| 2019 Q4 | 1.07 Billion CNY | -13.34% |
| 2018 Q2 | 1.33 Billion CNY | 11.51% |
| 2018 Q3 | 1.42 Billion CNY | 6.52% |
| 2018 Q1 | 1.19 Billion CNY | 13.95% |
| 2018 Q4 | 1.51 Billion CNY | 6.64% |
| 2018 FY | 5.48 Billion CNY | 80.2% |
| 2017 Q1 | 599.92 Million CNY | -32.81% |
| 2017 FY | 3.04 Billion CNY | 1.95% |
| 2017 Q3 | 724.03 Million CNY | 8.84% |
| 2017 Q4 | 1.05 Billion CNY | 45.39% |
| 2017 Q2 | 665.23 Million CNY | 10.89% |
| 2016 Q4 | 892.87 Million CNY | 21.58% |
| 2016 Q2 | 740.09 Million CNY | 20.07% |
| 2016 Q1 | 616.4 Million CNY | -18.21% |
| 2016 FY | 2.98 Billion CNY | 11.28% |
| 2016 Q3 | 734.36 Million CNY | -0.77% |
| 2015 FY | 2.68 Billion CNY | 40.69% |
| 2015 Q3 | 662.94 Million CNY | -10.05% |
| 2015 Q2 | 737.01 Million CNY | 39.69% |
| 2015 Q1 | 527.59 Million CNY | -1.2% |
| 2015 Q4 | 753.67 Million CNY | 13.69% |
| 2014 Q1 | 305.25 Million CNY | -14.65% |
| 2014 FY | 1.9 Billion CNY | 45.72% |
| 2014 Q3 | 465.25 Million CNY | -22.63% |
| 2014 Q2 | 601.34 Million CNY | 97.0% |
| 2014 Q4 | 533.97 Million CNY | 14.77% |
| 2013 Q2 | 409.48 Million CNY | 96.53% |
| 2013 Q3 | 332.37 Million CNY | -18.83% |
| 2013 Q4 | 357.66 Million CNY | 7.61% |
| 2013 FY | 1.3 Billion CNY | 83.94% |
| 2013 Q1 | 208.35 Million CNY | -16.36% |
| 2012 Q2 | 206.49 Million CNY | 63.07% |
| 2012 Q4 | 249.11 Million CNY | 93.43% |
| 2012 FY | 711.03 Million CNY | 30.14% |
| 2012 Q1 | 126.63 Million CNY | -26.33% |
| 2012 Q3 | 128.78 Million CNY | -37.63% |
| 2011 Q1 | 92.51 Million CNY | -54.14% |
| 2011 Q2 | 162.45 Million CNY | 75.59% |
| 2011 Q3 | 119.51 Million CNY | -26.43% |
| 2011 Q4 | 171.88 Million CNY | 43.83% |
| 2011 FY | 546.36 Million CNY | -5.05% |
| 2010 Q4 | 201.73 Million CNY | 46.64% |
| 2010 Q2 | 160.55 Million CNY | 112.4% |
| 2010 Q3 | 137.56 Million CNY | -14.32% |
| 2010 FY | 575.44 Million CNY | 33.85% |
| 2010 Q1 | 75.58 Million CNY | -52.45% |
| 2009 Q4 | 158.97 Million CNY | 58.64% |
| 2009 FY | 429.92 Million CNY | 55.99% |
| 2009 Q2 | 114.36 Million CNY | 102.82% |
| 2009 Q1 | 56.38 Million CNY | 0.0% |
| 2009 Q3 | 100.2 Million CNY | -12.38% |
| 2008 FY | 275.61 Million CNY | 67.94% |
| 2007 FY | 164.11 Million CNY | 0.0% |